NICE Proposals To Cut Patient Input Under Fire In UK
Executive Summary
Proposals from UK HTA body NICE that aim to increase capacity to meet the growing demand for appraisals have come under fire for downgrading the role of patients and clinicians.
You may also be interested in...
UK Industry Body Says NICE Appraisal Changes Don’t Go Far Enough
NICE, the health technology appraisal institute in the UK, should consider other changes to its appraisal processes beyond increasing efficiency, according to the Association of the British Pharmaceutical Industry.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.